[{"NetIncomeLoss_4_FY_USD":-103270000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4_FY_shares":25251968.0,"CommitmentsAndContingencies_0_FY_USD":0.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_FY_USD":3600000.0,"AccruedLiabilitiesCurrent_0_FY_USD":13411000.0,"DerivativeLiabilitiesCurrent_0_FY_USD":1264000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":83000.0,"IncomeTaxesPaid_4_FY_USD":11000.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":37874000.0,"PaymentsToAcquireInvestments_4_FY_USD":74562000.0,"ValuationAllowanceDeferredTaxAssetChangeInAmount_4_FY_USD":27800000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_4_FY_USD":29000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_FY_USD":922000.0,"AssetsCurrent_0_FY_USD":236350000.0,"OperatingLeaseExpense_4_FY_USD":600000.0,"DeferredTaxAssetsOperatingLossCarryforwards_0_FY_USD":26122000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4_FY_shares":5903227.0,"StockIssuedDuringPeriodValueStockOptionsExercised_4_FY_USD":328000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_FY_USD":893000.0,"ConversionOfStockAmountIssued1_4_FY_USD":0.0,"UnrecognizedTaxBenefits_0_FY_USD":3933000.0,"CommonStockSharesIssued_0_FY_shares":30032600.0,"Assets_0_FY_USD":240864000.0,"ShareBasedCompensation_4_FY_USD":12554000.0,"OperatingLeaseRightOfUseAsset_0_FY_USD":1949000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_FY_shares":8343673.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_FY_USD":0.0001,"GeneralAndAdministrativeExpense_4_FY_USD":22691000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_FY_USD":581000.0,"PreferredStockSharesOutstanding_0_FY_shares":0.0,"OperatingLeaseLiability_0_FY_USD":3263000.0,"DeferredTaxLiabilitiesLeasingArrangements_0_FY_USD":385000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_FY_USD":3844000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_4_FY_USD":85900000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_4_FY_USD":-75000.0,"OtherNonoperatingIncomeExpense_4_FY_USD":-192000.0,"IncomeTaxExpenseBenefit_4_FY_USD":6000.0,"ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_4_FY_USD":0.0,"CommonStockValue_0_FY_USD":3000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_FY_USD":0.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_FY_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4_FY_USD":107000.0,"PaymentOfFinancingAndStockIssuanceCosts_4_FY_USD":158000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_FY_USD":230000.0,"DepreciationDepletionAndAmortization_4_FY_USD":305000.0,"EffectiveIncomeTaxRateContinuingOperations_4_FY_pure":-0.0001,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_4_FY_USD":81605000.0,"ProceedsFromIssuanceOfPrivatePlacement_4_FY_USD":10000000.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":181288000.0,"UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_4_FY_USD":17000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":-103316000.0,"OtherAssetsNoncurrent_0_FY_USD":1272000.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":142086000.0,"OperatingLeaseLiabilityNoncurrent_0_FY_USD":2627000.0,"AdditionalPaidInCapitalCommonStock_0_FY_USD":345180000.0,"Liabilities_0_FY_USD":68769000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_4_FY_USD":784000.0,"DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_0_FY_USD":812000.0,"DeferredIncomeTaxLiabilities_0_FY_USD":569000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_FY_USD":930000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4_FY_USD":1827000.0,"CommonStockSharesAuthorized_0_FY_shares":200000000.0,"CommonStockSharesOutstanding_0_FY_shares":29776544.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_FY_USD":300000.0,"EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_pure":-0.2696,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4_FY_USD":-103264000.0,"ImpairmentOfLongLivedAssetsToBeDisposedOf_4_FY_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4_FY_USD":12554000.0,"PreferredStockLiquidationPreferenceValue_0_FY_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-89075000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_FY_USD":869000.0,"LiabilitiesCurrent_0_FY_USD":18462000.0,"AccountsPayableCurrent_0_FY_USD":3151000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_FY_USD":4530000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_4_FY_USD":29000.0,"CashAndCashEquivalentsFairValueDisclosure_0_FY_USD":139779000.0,"UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_4_FY_USD":2460000.0,"UndistributedEarningsOfForeignSubsidiaries_0_FY_USD":0.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4_FY_pure":0.21,"OperatingLeaseWeightedAverageDiscountRatePercent_0_FY_pure":0.08,"IncreaseDecreaseInOtherOperatingAssets_4_FY_USD":954000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_FY_USD":142086000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_4_FY_USD":456000.0,"EffectiveIncomeTaxRateReconciliationTaxCredits_4_FY_pure":0.0642,"NumberOfOperatingSegments_4_FY_Segment":1.0,"OperatingLeasePayments_4_FY_USD":576000.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_4_FY_USD":0.0,"PreferredStockSharesIssued_0_FY_shares":0.0,"PropertyPlantAndEquipmentNet_0_FY_USD":1293000.0,"DeferredTaxAssetsGross_0_FY_USD":47218000.0,"CurrentForeignTaxExpenseBenefit_4_FY_USD":6000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4_FY_USD":130116000.0,"PaymentsForTenantImprovements_4_FY_USD":0.0,"OperatingIncomeLoss_4_FY_USD":-104296000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_4_FY_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_FY_USD":89734000.0,"ProceedsFromIssuanceInitialPublicOffering_4_FY_USD":121087000.0,"InvestmentIncomeInterest_4_FY_USD":1559000.0,"PreferredStockValue_0_FY_USD":0.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":240864000.0,"EmployeeRelatedLiabilitiesCurrent_0_FY_USD":4801000.0,"PreferredStockSharesAuthorized_0_FY_shares":10000000.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":12554000.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":46649000.0,"OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_4_FY_USD":-46000.0,"EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_4_FY_pure":0.0042,"ShortTermInvestments_0_FY_USD":89734000.0,"OperatingLeaseLiabilityCurrent_0_FY_USD":636000.0,"DeferredTaxAssetsLiabilitiesNet_0_FY_USD":0.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4_FY_USD":0.0,"EarningsPerShareBasicAndDiluted_4_FY_USD":-4.09,"ProfitLoss_4_FY_USD":-103270000.0,"OtherLiabilitiesNoncurrent_0_FY_USD":29000.0,"StockholdersEquity_0_FY_USD":172095000.0,"PaymentsToAcquirePropertyPlantAndEquipment_4_FY_USD":225000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4_FY_USD":-103371000.0,"LongTermInvestments_0_FY_USD":0.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_4_FY_USD":-72000.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0_FY_USD":2769000.0,"DeferredTaxAssetsTaxCreditCarryforwards_0_FY_USD":11294000.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-173171000.0,"OperatingExpenses_4_FY_USD":104296000.0,"AccruedProfessionalFeesCurrent_0_FY_USD":2157000.0,"Ticker":"MIRM","CIK":"1759425","name":"MIRUM PHARMACEUTICALS, INC.","OfficialName":"Mirum Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"824673616.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210309"}]